Clinical Trial Update: Effect of Akkermansia Muciniphila WST01 Strain in Overweight or Obese Patients With Type 2 Diabetes [Phase 2]

View source ↗

Summary

Phase 2 study investigating the effects of Akkermansia muciniphila WST01 in overweight/obese patients with type 2 diabetes; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight
• Type 2 Diabetes Mellitus

Drugs mentioned

• Akkermansia muciniphila WST01 (Akkermansia muciniphila WST01 strain)

Snippet

Sponsor: Shanghai Jiao Tong University School of Medicine | Conditions: Obese, Overweight | Phase 2 | Status: UNKNOWN